Product Information
IMITREX 100 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $72.3760 per EA under NDC 00173073701. Its NADAC has been published 655 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the sumatriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173073701
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020132On Market Since
12/19/2003
Pharmacological Classes
Price Statistics
The NADAC for IMITREX 100 MG TABLET has been published 655 times since Nov 28, 2013, and over the history we have for it it has risen 121.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $72.3760 per EA |
|---|---|
| All-time high | $72.9867 (Jun 12, 2024) |
| All-time low | $32.7092 (Nov 28, 2013) |
| 52-week high | $72.5329 |
| 52-week low | $72.2993 |
| Median price | $64.7327 |
| Average price | $60.9611 |
| Largest weekly change | +15.0% (Jan 14, 2015) |
| Weeks tracked | 655 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMITREX 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IMITREX 100 MG TABLET, manufactured by GlaxoSmithKline LLC, is $72.3760 per EA (NDC 00173073701), effective Jun 24, 2026.
How has the price of IMITREX 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for IMITREX 100 MG TABLET has risen 121.3%. It has been tracked across 655 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMITREX 100 MG TABLET?
Since Nov 28, 2013, the NADAC for IMITREX 100 MG TABLET has ranged from a low of $32.7092 (Nov 28, 2013) to a high of $72.9867 (Jun 12, 2024), with a median of $64.7327 per EA.
Are there cheaper alternatives to IMITREX 100 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SUMATRIPTAN SUCC 100 MG TABLET, is $0.4341 per EA — about 99% below IMITREX 100 MG TABLET.
Who manufactures IMITREX 100 MG TABLET?
IMITREX 100 MG TABLET (NDC 00173073701) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification